Federal Circuit remands Hospira’s on-sale bar question

07-02-2018

Federal Circuit remands Hospira’s on-sale bar question

ericsphotography / iStockphoto.com

The US Court of Appeals for the Federal Circuit yesterday affirmed a district court’s findings that Hospira doesn’t infringe two patents owned by biopharma firm The Medicines Company, while remanding an on-sale bar question. 


Hospira, The Medicines Company, US Court of Appeals for the Federal Circuit, patent, on-sale bar, patent infringement

LSIPR